External anti-inflammatory drug from the Miao nationality and production process thereof

A preparation process and anti-inflammatory drug technology, applied in the field of anti-inflammatory drugs for external use, can solve problems such as single function and unsatisfactory curative effect

Inactive Publication Date: 2013-01-02
何兆辉 +2
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, although there are these medicines and preparations with various na

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] 2 parts of honeysuckle, 1 part of dog ridge, 1 part of goldenrod, 1 part of woad, 2 parts of butterfly flower, 1 part of dandelion, 2 parts of wild chrysanthemum; total 1000g.

[0041] Preparation steps:

[0042] All the medicinal materials are crushed to a fineness of 50 mesh sieve, 2kg of 95% ethanol is added, and the medicinal materials are impregnated for 2 hours in an airtight manner; a fully and uniformly wetted and expanded medicinal powder can be obtained;

[0043] The impregnated drug powder is evenly loaded into the percolation cylinder in a uniform tightness. In order to ensure consistent tightness, a layered partition with holes is specially set up; add 2kg of 95% ethanol and impregnate in a sealed container for 48 hours;

[0044] Percolate at a rate of 2 mL per minute of 1000 g of medicinal materials, add 60% ethanol at the same speed, and the addition amount is 2 kg; when the collected percolation volume reaches 3.5 kg, the percolation solution (1) is obtain...

Embodiment 2

[0049] 3 parts of honeysuckle, 2 parts of dog ridge, 2 parts of goldenrod, 1 part of woad, 3 parts of butterfly flower, 2 parts of dandelion, 3 parts of wild chrysanthemum; the total amount is 1000g.

[0050] Preparation steps:

[0051] All the medicinal materials are crushed to the fineness of passing through a 30-mesh sieve, 2kg of 95% ethanol is added, and the medicinal materials are sealed and impregnated for 2 hours; a fully and uniformly wetted and expanded medicinal powder is obtained;

[0052] The impregnated medicinal powder is evenly and loosely loaded into the percolation cylinder, and 2kg of 95% ethanol is added, and impregnated for 48 hours in a closed manner;

[0053] Percolate at a rate of 2 mL per minute of 1000 g of medicinal materials, add 60% ethanol at the same speed, and the addition amount is 2 kg; when the collected percolation volume reaches 3.5 kg, the percolation solution (1) is obtained;

[0054] Continue percolation, add purified water at the same ...

Embodiment 3

[0058] 3 parts of honeysuckle, 3 parts of dog ridge, 3 parts of goldenrod, 1 part of woad, 4 parts of butterfly flower, 2 parts of dandelion, 2 parts of wild chrysanthemum; total 1000g.

[0059] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an external anti-inflammatory drug prepared from the raw materials of medicinal plants used by the Miao nationality. The external anti-inflammatory drug comprises the following components: 2-4 parts of honeysuckle, 1-3 parts of rhizoma cibotii, 1-3 parts of solidago decurrens, 1-2 parts of woad, 2-4 parts of fringed iris, 1-3 parts of dandelion and 2-3 parts of chrysanthemum. The external anti-inflammatory drug is an integrity of anti-inflammatory agent, cleaning agent, bath agent and antipruritic agent. The indications and usages of the external anti-inflammatory drug are more than those of the currently widely used drugs and preparations, such as Daktarin cream, calamine and menthol lotion, Jieeryin, Fu Yanjie, external zijin troches, Chuanbai anti-itching lotion, Shibiling anti-itching anti-inflammatory lotion and Sanwei heat-clearing anti-itching lotion. The preparation prepared from the formula contains no chemicals, and is a pure natural medicinal plant preparation; besides, the external anti-inflammatory drug has no toxic or side effect, or irritation on skin and mucosa of adult and infant, and is an essential household medicine.

Description

technical field [0001] The invention relates to an anti-inflammatory drug for external use made from medicinal plants of the Miao nationality. Background technique [0002] Women's gynecological inflammation, baby eczema, baby red buttocks, and children's skin inflammation caused by mosquito bites are common clinical inflammations and are also common diseases in family health care. Many doctors and pharmaceutical companies are working hard to innovate safe and effective local therapeutic drugs for the treatment of these inflammations. [0003] At present, although there are these medicines and preparations with various names, they all have insufficient curative effect or single function limitation. Therefore, it is urgent to develop a kind of non-toxic, non-irritating to human urogenital skin, mucous membranes, infant skin and mucous membranes, without chemical additives, broad-spectrum anti-pathogenic microorganisms, strong anti-inflammatory effect, wide application range,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/88A61P15/02A61P13/02A61P17/00
Inventor 袁涛忠何兆辉黄玉珍
Owner 何兆辉
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products